A new study carried out by researchers at the Johns Hopkins University (MD, USA) has provided evidence of an association between mild cognitive decline and levels of serotonin. The study, published in Neurobiology of Disease, proposes the use of serotonin receptors as a biomarker to detect cognitive and possible dementia development.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.